SavedAdd your journal

Journals / Retina-Vitreus / 2012 / Cilt: 20 - Sayı: 1

Treatment of central retinal vein occlusion in a patient with systemic lupus erythematosus and hemodialysis by bevacizumab

Sistemik lupus eritematosus ve hemodializ hastasında gelişen santral retinal ven tıkanıklığının bevacizumab ile tedavisi

Dilek GÜVEN
Ayşegül MAVİ
Pınar AKARSU
Cemile ATILGAN ÜÇGÜL
Pages
70–73
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This study reports development of central retinal vein occlusion and its treatment using intravitreal bevacizumab in a 40 year-old female patient who was diagnosed as systemic lupus erythematosus for 10 years and was under hemodialysis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:This study reports development of central retinal vein occlusion and its treatment using intravitreal bevacizumab in a 40 year-old female patient who was diagnosed as systemic lupus erythematosus for 10 years and was under hemodialysis.
📊
Key Findings & Data:This study reports development of central retinal vein occlusion and its treatment using intravitreal bevacizumab in a 40 year-old female patient who was diagnosed as systemic lupus erythematosus for 10 years and was under hemodialysis.
💡
Conclusion & Impact:This study reports development of central retinal vein occlusion and its treatment using intravitreal bevacizumab in a 40 year-old female patient who was diagnosed as systemic lupus erythematosus for 10 years and was under hemodialysis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

This study reports development of central retinal vein occlusion and its treatment using intravitreal bevacizumab in a 40 year-old female patient who was diagnosed as systemic lupus erythematosus for 10 years and was under hemodialysis.

Özet

Bu çalışmada 10 yıldır sistemik lupus eritematozus tanısı olan ve kronik böbrek yetmezliği nedeniyle hemodializ gören 40 yaşındaki bayan hastada gelişen santral retinal ven tıkanıklığı ve intravitreal bevacizumab ile tedavisi sunulmaktadır.

🔖

Cite This Article

GÜVEN, D., MAVİ, A., AKARSU, P., ÜÇGÜL, C. A. (2012). Treatment of central retinal vein occlusion in a patient with systemic lupus erythematosus and hemodialysis by bevacizumab. Retina-Vitreus, Cilt: 20 - Sayı: 1, 70–73. https://ajindex.com/articles/307909

References (13)

  1. Gold DH, Morris DA, Henkind P. Ocular findings in systemic lupus erythematosus.Br J Ophthalmol 1972;56:800-4
  2. Sivaraj RR, Durrani OM, Denniston AK, et al. Ocular manifestations of systemic lupus erythematosus. Rheunatology 2007;46:1757-62
  3. Coppeto J, Lessel S. Retinopathy in systemic lupus erythematosus. Arch Ophthalmol 1977;95:794-7
  4. Karpik AG, Schwartz MM, Dickey LE, et al. Ocular immune reactants in patients dying with systemic lupus erythematosus. Clin Immunol immunopathol 1985;35:295-312
  5. Baglio V, Gharbiya M, Balacco-Gabrieli C, et al. Choroidopathy in patients with systemic lupus erythematosus with and without nephropathy 2011;24:522-9
  6. Aronson AJ, Ordonez NG, Diddie KR, et al. Immune complex deposition in the eye in systemic lupus erythematosus. Arch Intern Med 1979;139:1312-3
  7. Duvall-Young J, MacDonald MK, McKechnie NM. Fundus changes in type II mesangiocapillary glomerulonephritis simulating drusen: a histopathological report. 1989;73:297-302
  8. Asherson RA, Merry P, Acheson JF, et al. Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the primary antiphospholipid syndrome. Ann Rheum Dis 1989;48:358-61
  9. Au A, O’Day J. Review of severe vaso-occlusive retinopathy in systemic lupus erythematosus and the antiphospholipid syndrome: associations, visual outcomes, complications and treatment. Clin Experiment Ophthalmol 2004;32:87-100
  10. Mendrinos E, Mavrakanas N, Kiel R, et al. Bilateral combined central retinal artery and vein occlusion in systemic lupus erythematosus resulting in complete blindness. Eye 2009;23:1231-2
  11. Carvalho JF, Blank M, Shoenfeld Y. Vascular endothelial growth factor (VEGF) in autoimmune diseases. J Clin Immunol 2007;27:246-56
  12. Kunavisarut P, Pathanapitoon K, Chantarasorn Y, et al. Severe occlusive retinal vasculitis in systemic lupus erythematosus: a case report. Chiang MaiMed J 2009;48:159-62
  13. Kurup S, Lew J, Byrnes G, et al. Acta Ophthalmol 2009;87:349- 52.